There was no statistical evidence of a differential effect of apixaban on clinical events or bleeding in patients with or without prior HF ; however , among patients with acute HF , there were numerically fewer events with apixaban than placebo ( @ vs @ , HR @ , @ % CI @-@ @ , interaction P = @ ) , a trend that was not seen in patients with prior HF or no HF .